ATE43968T1 - Hapten- und muramylpeptidkonjugate, mit immunogenischer wirksamkeit und die selben enthaltende zubereitungen. - Google Patents

Hapten- und muramylpeptidkonjugate, mit immunogenischer wirksamkeit und die selben enthaltende zubereitungen.

Info

Publication number
ATE43968T1
ATE43968T1 AT83400525T AT83400525T ATE43968T1 AT E43968 T1 ATE43968 T1 AT E43968T1 AT 83400525 T AT83400525 T AT 83400525T AT 83400525 T AT83400525 T AT 83400525T AT E43968 T1 ATE43968 T1 AT E43968T1
Authority
AT
Austria
Prior art keywords
hapten
muramylpeptide
conjugates
same
preparations containing
Prior art date
Application number
AT83400525T
Other languages
English (en)
Inventor
Francoise Audibert
Claude Carelli
Louis Chedid
Pierre Lefrancier
Michel Level
Jean Choay
Original Assignee
Anvar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anvar filed Critical Anvar
Application granted granted Critical
Publication of ATE43968T1 publication Critical patent/ATE43968T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/385—Haptens or antigens, bound to carriers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/001—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure
    • C07K9/005—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure containing within the molecule the substructure with m, n > 0 and m+n > 0, A, B, D, E being heteroatoms; X being a bond or a chain, e.g. muramylpeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6062—Muramyl peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/13—Luteinizing hormone-releasing hormone; related peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/15—Oxytocin or vasopressin; related peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/16—Somatostatin; related peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT83400525T 1982-03-15 1983-03-15 Hapten- und muramylpeptidkonjugate, mit immunogenischer wirksamkeit und die selben enthaltende zubereitungen. ATE43968T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8204353A FR2522967B1 (fr) 1982-03-15 1982-03-15 Conjugues d'haptenes et de muramyl-peptides, doues d'activite immunogene et compositions les contenant
EP83400525A EP0089290B1 (de) 1982-03-15 1983-03-15 Hapten- und Muramylpeptidkonjugate, mit immunogenischer Wirksamkeit und die selben enthaltende Zubereitungen

Publications (1)

Publication Number Publication Date
ATE43968T1 true ATE43968T1 (de) 1989-06-15

Family

ID=9272016

Family Applications (1)

Application Number Title Priority Date Filing Date
AT83400525T ATE43968T1 (de) 1982-03-15 1983-03-15 Hapten- und muramylpeptidkonjugate, mit immunogenischer wirksamkeit und die selben enthaltende zubereitungen.

Country Status (12)

Country Link
US (1) US4639512A (de)
EP (1) EP0089290B1 (de)
JP (1) JPH0720882B2 (de)
AT (1) ATE43968T1 (de)
AU (1) AU570405B2 (de)
CA (1) CA1193216A (de)
DE (1) DE3380053D1 (de)
DK (1) DK120383A (de)
ES (1) ES8608883A1 (de)
FR (1) FR2522967B1 (de)
HU (1) HU195620B (de)
SU (1) SU1331433A3 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2546756B1 (fr) * 1983-06-03 1985-11-29 Centre Nat Rech Scient Nouveaux derives immunostimulants, leur preparation et leur application comme medicament
FR2558165B1 (fr) * 1984-01-17 1986-07-04 Anvar Nouveaux conjugues d'oligo-muramylpeptides et compositions biologiques les contenant pour l'activation des macrophages
LU85269A1 (fr) * 1984-03-26 1985-10-14 Techland S A Composes nouveaux de somatostatine,procede pour leur synthese,preparation a usage veterinaire contenant lesdits composes et procede pour le traitement d'animaux
FR2569984B1 (fr) * 1984-09-12 1987-08-14 Anvar Molecule synthetique contenant une pluralite d'epitopes distincts, procede pour son obtention et application a la production de polyvaccins
US6024964A (en) * 1985-06-24 2000-02-15 Hoechst Aktiengesellschaft Membrane anchor/active compound conjugate, its preparation and its uses
US6074650A (en) * 1985-06-24 2000-06-13 Hoechst Aktiengesellschaft Membrane anchor/active compound conjugate, its preparation and its uses
DK585886A (da) * 1985-12-24 1987-06-25 Takeda Chemical Industries Ltd Immunstimulerende middel og anvendelse deraf
JPH07121871B2 (ja) * 1986-10-09 1995-12-25 国立予防衛生研究所長 インフルエンザワクチン凍結乾燥製剤
HU906340D0 (en) * 1986-10-13 1991-04-29 Sandoz Ag Synthesis in solid phase for producing peptonic alcohols
GB8713240D0 (en) * 1987-06-05 1987-07-08 Proteus Biotech Ltd Hormones
US4975420A (en) * 1987-09-30 1990-12-04 University Of Saskatchewan Agents and procedures for provoking an immune response to GnRH and immuno sterilizing mammals
FR2623715B1 (fr) * 1987-11-26 1990-12-21 Lafon Labor Structures peptidiques, immunogenes les contenant et leurs applications au controle de la fertilite
DE4010645A1 (de) * 1990-02-10 1991-08-14 Gerhard Dr Prinzhaus Synthetisches peptid: thymosin (alpha)(pfeil abwaerts)1(pfeil abwaerts) - mdp - lys (t (alpha)(pfeil abwaerts)1(pfeil abwaerts)-nacmur-l-ala-d-isogln-l-lys)
FR2732604B1 (fr) * 1995-04-07 1997-06-06 Vacsyn Sa Derives et conjugues du mdp presentant une activite stimulatrice de la fonction hematopoietique et compositions les contenant
GB9924351D0 (en) 1999-10-14 1999-12-15 Brennan Frank Immunomodulation methods and compositions
NZ511705A (en) * 2001-05-14 2004-03-26 Horticulture & Food Res Inst Methods and rapid immunoassay device for detecting progesterone and other steroids
US6561915B2 (en) * 2001-10-09 2003-05-13 Mattel, Inc. Infant swing and method of using the same
EP1590440A4 (de) * 2003-02-03 2009-03-18 Palo Alto Inst Of Molecular Me Zellabtötende moleküle und vefahren zu deren verwendung
AU2004278748B2 (en) * 2003-09-29 2008-09-11 The Regents Of The University Of California Methods for altering hematopoietic progenitor cell adhesion, differentiation, and migration
CN101784655A (zh) * 2007-04-27 2010-07-21 菲尼克斯股份有限公司 可溶性重组二十面体病毒样颗粒的改良生成和体内装配
CN107735404A (zh) 2014-11-21 2018-02-23 尼古拉·弗拉基米罗维奇·鲍文 多价配体‑脂质构建体

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2292486A1 (fr) * 1974-07-01 1976-06-25 Anvar Adjuvants immunologiques solubles dans l'eau, notamment pour vaccins, obtenus a partir de microbacteries et autres micro-organismes
IL48325A (en) * 1974-10-22 1979-05-31 Anvar Immunological-free adjuvant compositions containing n-acetyl muramyl-alanyl-d-isoglutamine or n-acetyl-muramyl-l-alanyl-d-glutamicn acid
FI66878C (fi) * 1978-02-24 1984-12-10 Ciba Geigy Ag Foerfarande foer framstaellning av nya antigenderivat
US4397844A (en) * 1978-02-24 1983-08-09 Ciba-Geigy Corporation Antigen derivatives and processes for their preparation

Also Published As

Publication number Publication date
JPS58208237A (ja) 1983-12-03
US4639512A (en) 1987-01-27
FR2522967B1 (fr) 1986-03-07
DK120383D0 (da) 1983-03-15
EP0089290B1 (de) 1989-06-14
ES8608883A1 (es) 1986-07-16
DE3380053D1 (en) 1989-07-20
CA1193216A (fr) 1985-09-10
SU1331433A3 (ru) 1987-08-15
AU570405B2 (en) 1988-03-17
EP0089290A1 (de) 1983-09-21
JPH0720882B2 (ja) 1995-03-08
ES520915A0 (es) 1986-07-16
HU195620B (en) 1988-06-28
DK120383A (da) 1983-09-16
AU1248583A (en) 1983-09-22
FR2522967A1 (fr) 1983-09-16

Similar Documents

Publication Publication Date Title
ATE43968T1 (de) Hapten- und muramylpeptidkonjugate, mit immunogenischer wirksamkeit und die selben enthaltende zubereitungen.
EA199700272A1 (ru) Вакцины, содержащие сапонин и стерин
FI903292A0 (fi) T-cellepitop som baerarmolekyler foer konjugerade vacciner.
ATE529130T1 (de) Trockenformulierung für transkutane immunisierung
DK190387D0 (da) Vaccine
NO950739D0 (no) Vaksiner mot gruppe C Neisseria Meningtidis
JPS557287A (en) Aryloxypropanol amine
FR2416014A1 (fr) Antigene pour un test de detection precoce de la grossesse et un vaccin contraceptif
ES553425A0 (es) Perfeccionamientos en la fabricacion de conjugados de proteinas portadores de antigenos inmunogenicos para vacunas contra la malaria
DE69129747T2 (de) In lösung bringen von proteinen in aktiver form
DK101196A (da) Histaminderivat, histamin-immunogen-konjugat samt antistof fremstillet mod konjugatet
DE69231495T2 (de) Neue cocain-derivate und protein- und polypeptid-cocain-derivate, konjugate und markierte verbindungen
DK0636030T3 (da) Pasteurella haemolytica type A-1-bacterin-toxoid-vaccine
DE3777196D1 (de) Anti-parathyroid-antikoerper-praeparat.
CO5241277A1 (es) Vacuna
WO1990015132A3 (en) Cloned treponema hyodysenteriae endoflagellar antigen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties